drugset / Trial / NCT07798258

Assessment of Injectable PRF Versus Dextrose Injection in Temporomandibular Joint in Anterior Disc Displacement With Reduction

NCT07798258 ↗

Phase 2 Active not recruiting 24 enrolled Cairo University
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized clinical trial aims to compare the accuracy and effectiveness of injectable platelet-rich fibrin (I-PRF) versus 25% dextrose prolotherapy injected into retrocondylar tissues in patients with anterior disc displacement with reduction of the temporomandibular joint. The study will evaluate improvement in disc position, pain, mouth opening, and clicking sounds following treatment.

Timeline

Start
2025-10-10
Primary completion
2027-01-10
Completion
2027-02-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dextrose Unknown 1.5 ml Other
Subject Platelet rich fibrin Other / unclassified 1.5 ml Other
Comparator Levonordefrin Small molecule — Other
Comparator Mepivacaine Other / unclassified 2 % Other